BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35685724)

  • 1. Exploring the Effect and Mechanism of Si-Miao-Yong-An Decoction on Abdominal Aortic Aneurysm Based on Mice Experiment and Bioinformatics Analysis.
    Xu Z; Zhang L; Huangfu N; Jiang F; Ji K; Wang S
    Evid Based Complement Alternat Med; 2022; 2022():4766987. PubMed ID: 35685724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-An decoction against thromboangiitis obliterans.
    Zou J; Xu W; Li Z; Gao P; Zhang F; Cui Y; Hu J
    Ann Med; 2023 Dec; 55(1):2218105. PubMed ID: 37318081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasma metabonomics study on the therapeutic effects of the Si-miao-yong-an decoction in hyperlipidemic rats.
    Shi S; Liu Z; Xue Z; Chen X; Chu Y
    J Ethnopharmacol; 2020 Jun; 256():112780. PubMed ID: 32222575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissection of mechanisms of Chinese medicinal formula Si-Miao-Yong-an decoction protects against cardiac hypertrophy and fibrosis in isoprenaline-induced heart failure.
    Zhao Y; Jiang Y; Chen Y; Zhang F; Zhang X; Zhu L; Yao X
    J Ethnopharmacol; 2020 Feb; 248():112050. PubMed ID: 31265887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the effective combinatorial components from Si-Miao-Yong-An decoction regarding the intervention on myocardial hypertrophy.
    Chen XY; Chen XH; Li L; Su CP; Zhang YL; Jiang YY; Guo SZ; Liu B
    J Ethnopharmacol; 2021 May; 271():113833. PubMed ID: 33465437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Si-Miao-Yong-An Decoction for Diabetic Retinopathy: A Combined Network Pharmacological and
    Du A; Xie Y; Ouyang H; Lu B; Jia W; Xu H; Ji L
    Front Pharmacol; 2021; 12():763163. PubMed ID: 34899317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models.
    Liao M; Xie Q; Zhao Y; Yang C; Lin C; Wang G; Liu B; Zhu L
    Pharmacol Res; 2022 Feb; 176():106077. PubMed ID: 35026404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Si-Miao-Yong-An decoction attenuates cardiac fibrosis via suppressing TGF-β1 pathway and interfering with MMP-TIMPs expression.
    Su C; Wang Q; Luo H; Jiao W; Tang J; Li L; Tian L; Chen X; Liu B; Yu X; Li S; Guo S; Wang W
    Biomed Pharmacother; 2020 Jul; 127():110132. PubMed ID: 32403042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Si-Miao-Yong-An decoction ameliorates cardiac function through restoring the equilibrium of SOD and NOX2 in heart failure mice.
    Ren Y; Chen X; Li P; Zhang H; Su C; Zeng Z; Wu Y; Xie X; Wang Q; Han J; Guo S; Liu B; Wang W
    Pharmacol Res; 2019 Aug; 146():104318. PubMed ID: 31228552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation.
    Su C; Wang Q; Zhang H; Jiao W; Luo H; Li L; Chen X; Liu B; Yu X; Li S; Wang W; Guo S
    Front Pharmacol; 2019; 10():990. PubMed ID: 31619988
    [No Abstract]   [Full Text] [Related]  

  • 11. Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury.
    Cui W; Xin S; Zhu L; Wang M; Hao Y; Zhao Y; Li Y; Hou Y
    Evid Based Complement Alternat Med; 2021; 2021():8968464. PubMed ID: 34367308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Si-Miao-Yong-An Decoction attenuates isoprenaline-induced myocardial fibrosis in AMPK-driven Akt/mTOR and TGF-β/SMAD3 pathways.
    Zhao Y; Sun D; Chen Y; Zhan K; Meng Q; Zhang X; Zhu L; Yao X
    Biomed Pharmacother; 2020 Oct; 130():110522. PubMed ID: 32736236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of classic neutral bile acids synthesis pathway is responsible for cholesterol-lowing effect of Si-miao-yong-an decoction: Application of LC-MS/MS method to determine 6 major bile acids in rat liver and plasma.
    Liu Z; Zhang Y; Zhang R; Gu L; Chen X
    J Pharm Biomed Anal; 2017 Feb; 135():167-175. PubMed ID: 28033554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic investigation of the material basis, multiple mechanisms and quality control of Simiao Yong'an decoction combined with antibiotic in the treatment of sepsis.
    Cai Z; He J; Jiang J; Zhao Z; Shu Y
    Phytomedicine; 2023 Jul; 116():154910. PubMed ID: 37267690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evidence update to explore molecular targets and protective mechanisms of apigenin against abdominal aortic aneurysms based on network pharmacology and experimental validation.
    Li D; Wang L; Jiang B; Miao Y; Li X
    Mol Divers; 2023 Aug; ():. PubMed ID: 37653360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm.
    Li Y; Lu G; Sun D; Zuo H; Wang DW; Yan J
    PLoS One; 2017; 12(4):e0174821. PubMed ID: 28369137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-144-5p limits experimental abdominal aortic aneurysm formation by mitigating M1 macrophage-associated inflammation: Suppression of TLR2 and OLR1.
    Shi X; Ma W; Li Y; Wang H; Pan S; Tian Y; Xu C; Li L
    J Mol Cell Cardiol; 2020 Jun; 143():1-14. PubMed ID: 32278833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    Spinosa M; Su G; Salmon MD; Lu G; Cullen JM; Fashandi AZ; Hawkins RB; Montgomery W; Meher AK; Conte MS; Sharma AK; Ailawadi G; Upchurch GR
    J Vasc Surg; 2018 Dec; 68(6S):93S-103S. PubMed ID: 30470363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tauroursodeoxycholic Acid Attenuates Angiotensin II Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-deficient Mice by Inhibiting Endoplasmic Reticulum Stress.
    Qin Y; Wang Y; Liu O; Jia L; Fang W; Du J; Wei Y
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):337-345. PubMed ID: 27889204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of abdominal aortic aneurysms in mice is enhanced by benzo(a)pyrene.
    Zhang Y; Ramos KS
    Vasc Health Risk Manag; 2008; 4(5):1095-102. PubMed ID: 19183758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.